For instance, aberrant histone deacetylation by HDACs in liver cancer suppresses HNF4α transcriptional activity, whereas in PDAC, enhanced HNF4α binding to oncogenic loci drives malignancy [144]. Here, HNF4A is linked to liver cancer.